Flaig TW, Spiess PE, Abern M, Agarwal N, Bangs R, et al. NCCN Guidelines® insights: bladder cancer, version 2.2022: featured updates to the nccn guidelines. J Natl Compr Cancer Netw. 2022;20(8):866–78. https://doi.org/10.6004/jnccn.2022.0041.
Chang SS, Boorjian SA, Chou R, et al. Diagnosis and treatment of non-muscle invasive bladder cancer: AUA/SUO guideline. J Urol. 2016;196:1021.
Larsen ES, Joensen UN, Poulsen AM, Goletti D, Johansen IS. Bacillus Calmette-Guérin immunotherapy for bladder cancer: a review of immunological aspects, clinical effects and BCG infections. APMIS. 2020;128(2):92–103. https://doi.org/10.1111/apm.13011.
Yong C, Steinberg RL, O’Donnell MA. Severe infectious complications of intravesical Bacillus Calmette-Guérin: a case series of 10 patients. Urology. 2020;137:79–83. https://doi.org/10.1016/j.urology.2019.10.013.
Cabas P, Rizzo M, Giuffrè M, Antonello RM, Trombetta C, Luzzati R, et al. BCG infection (BCGitis) following intravesical instillation for bladder cancer and time interval between treatment and presentation: A systematic review. Urol Oncol. 2021;39(2):85–92. https://doi.org/10.1016/j.urolonc.2020.11.037.
Shibutani K, Ishikawa K, Mori N. Uncommon but Clinically Significant: Bacillus Calmette-Guerin (BCG) Infection of the Urinary Tract and its Impact on Quality of Life. Am J Case Rep. 2023;24:e940375 (United States 2023).
Article PubMed PubMed Central Google Scholar
• Loukil A, Baron SA, Argemi X, Maubon T, Eldin C. Microscopic detection of bacillus Calmette–Guérin mycobacteria in bladder biopsy using fluorescence in situ hybridization. New Microbes New Infect. 2021;39. https://doi.org/10.1016/j.nmni.2020.100826. A well-detailed publication discussing the use of fluorescence in situ hybridization (FISH) as anadditional diagnostic tool for bladder biopsy in patients with a suspicion of BCG infection.
• Sharma V, Thakur APS, Ramasamy V, Shukla PK, Solanki FS, Choudhary A, et al. Complications of intravesical BCG therapy in non-muscle invasive bladder cancer: our tertiary care centre experience. Afr J Urol. 2020;26(1). https://doi.org/10.1186/s12301-020-00099-6. A comprehensive retrospective descriptive study assessing the complications of intravesical BCGtherapy and their management in NMIBC patients at a tertiary care center in India.
Markovitz GH. Two cases of Bacillus Calmette-Guérin cystitis treated with hyperbaric oxygen. Undersea Hyperb Med. 2022;49(2):191–5.
Larsen ES, Nordholm AC, Lillebaek T, Holden IK, Johansen IS. The epidemiology of bacille Calmette-Guérin infections after bladder instillation from 2002 through 2017: a nationwide retrospective cohort study. BJU Int. 2019;124(6):910–6. https://doi.org/10.1111/bju.14793.
Nurminen P, Ettala O, Uusitalo-Seppälä R, Nummi A, Järvinen R, Antti K, et al. Incidence of and mortality from Bacille Calmette-Guérin (BCG) infections after BCG instillation therapy. BJU Int. 2022;129(6):737–43. https://doi.org/10.1111/bju.15608.
Article CAS PubMed Google Scholar
Nurminen P, Ettala O, Uusitalo-Seppälä R, Högerman M, Kaipia A, Boström PJ. Clinical presentation of bacille Calmette-Guérin (BCG) infections after BCG instillation therapy. BJU Int. 2023;131(3):306–12. https://doi.org/10.1111/bju.15870.
Nitti M, Faulk A, Westerman MB, Gills J, Delacroix S, Krlin R, et al. BCG cystitis: understanding impacts on bladder symptoms and function. Neurourol Urodyn. 2023;42:S303–4. https://doi.org/10.1002/nau.25154.
Medina-González M, Panach-Navarrete J, Mata-Cano D, Martínez Jabaloyas JM. Microbladder due to Granulomatous Cystitis Secondary to BCG Treatment. Arch Esp Urol. 2022;75:729–30 (Spain 2022).
Lee HY, Jung SI, Lim DG, Chung HS, Hwang EC, Kwon DD. Role of oral pentosan polysulfate in Bacillus Calmette-Guérin therapy in patients with non-muscle-invasive bladder cancer. Investig Clin Urol. 2022;63(5):539–45. https://doi.org/10.4111/icu.20220179.
Article PubMed PubMed Central Google Scholar
Inyang E, Nadeem M, Morris-Laverick J, Bezemer S. The efficacy of intravesical ialuril in the management of recurrent urinary tract infections and painful bladder syndrome. Neurourol Urodyn. 2023;42:S220. https://doi.org/10.1002/nau.25154.
Huang D, Jin YH, Weng H, Huang Q, Zeng XT, Wang XH. Combination of Intravesical bacille calmette-guérin and chemotherapy vs. Bacille calmette-guérin alone in non-muscle invasive bladder cancer: a meta-analysis. Front Oncol. 2019;9:121. https://doi.org/10.3389/fonc.2019.00121.
Article PubMed PubMed Central Google Scholar
Akiyama Y, Daichi M, Katoh H, Kume H, Homma Y. Comparative transcriptome analysis of interstitial cystitis/bladder pain syndrome with hunner lesions and bacillus calmette-guerin related cystitis by next-generation rna-sequencing: Discovery of disease-specific genes and associated biological pathways. J Urol. 2020;203:e95–6. https://doi.org/10.1097/JU.0000000000000827.02.
Waked R, Choucair J, Chehata N, Haddad E, Saliba G. Intravesical Bacillus Calmette-Guérin (BCG) treatment’s severe complications: A single institution review of incidence, presentation and treatment outcome. J Clin Tuberc Other Mycobact Dis. 2020;19:100149 (England: © 2020 The Authors).
Article CAS PubMed PubMed Central Google Scholar
Matsuoka Y, Taoka R, Kohashiguchi K, Tohi Y, Miyauchi Y, Kato T, et al. Efficacy and toxicity of intravesical Bacillus Calmette-Guérin therapy in elderly patients with non-muscle-invasive bladder cancer. Curr Urol. 2021;15(1):16–21. https://doi.org/10.1097/cu9.0000000000000011.
Article CAS PubMed PubMed Central Google Scholar
Haddaway NR, Page MJ, Pritchard CC, McGuinness LA. PRISMA2020: An R package and Shiny app for producing PRISMA 2020-compliant flow diagrams, with interactivity for optimised digital transparency and Open Synthesis. Campbell Syst Rev. 2022;18:e1230. https://doi.org/10.1002/cl2.1230.
Comments (0)